200+ leading industry players from vaccines and public health are already registered to attend this congress. Even more are attending this congress than ever before from all over the world. Exhibition almost sold out only a few opportunities left for your company to take part. 2 cocktail receptions - This is your chance to network with your colleagues and peers. Due to demand we have secured even more hotels with preferential rates for you. Accessing the leading minds in the vaccine community The new conference format mean you have more choice You can get dedicated updates on: Malaria, Rotavirus, HPV, TB, Poxvirus, HIV You can choose from three working groups for more in-depth discussion Networking program to enhance your congress experience Post-conference workshop Negotiating partnership deals Pre-conference briefing Biodefense Register now! “The event was very good, especially for someone trying to get an overall picture of the vaccine industry"  Angelo Hatzitolios, Project Manager, sanofi pasteur “An excellent blend of decision makers with whom to network" Daniel Tuse, VP Business Development, LSBC “I wanted to say that the recent World Vaccine Congress meeting was very informative and I wanted to thank you for doing an excellent job in the organisation of the meeting" Dr Raymond See, Programme Director, Vaccine Development, SAVI New for 2005 Pre-congress briefing Post-conference workshop Afternoon sessions Interactive working sessions Biodefense Negotiating partnership deals Clinical case studies - Influenza and avian flu - Vaccine delivery and adjuvants - Therapeutic and prophylactic vaccines book NOW book NOW FREE for delegates FREE for delegates

Global industry leaders include: Julian Lob-Levyt Vaccine Fund Chief Executive Officer and GAVI Executive Secretary Dr Reinhard Glück  Director of R&D Berna Biotech Dr Una Ryan President & CEO  AVANT Immnunotherapeutics    Dr Luc Hessel Executive Director Medical & Public Affairs sanofi pasteur     Dr Klaus Stohr Coordinator, Global Influenza Programme WHO     Dr Ronald Neeleman Manager Influenza Vaccine Dev. Solvay Pharmaceutical Dr Mark Abdy Veterinary Medical Officer FDA-CBER Dr Klaus Neurohr Head of Quality and Regulatory Affairs Avecia Dr Stephen Chatfield Chief Scientific Officer Emergent Biosolutions   and many more, click here >>